These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9437719)

  • 1. Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin.
    Banks WA; Jaspan JB; Kastin AJ
    Peptides; 1997; 18(10):1577-84. PubMed ID: 9437719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse.
    Banks WA; Farr SA; Morley JE
    J Gerontol A Biol Sci Med Sci; 2000 Dec; 55(12):B601-6. PubMed ID: 11129390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose and insulin increase the transport of leptin through the blood-brain barrier in normal mice but not in streptozotocin-diabetic mice.
    Kastin AJ; Akerstrom V
    Neuroendocrinology; 2001 Apr; 73(4):237-42. PubMed ID: 11340337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin.
    Banks WA; Jaspan JB; Huang W; Kastin AJ
    Peptides; 1997; 18(9):1423-9. PubMed ID: 9392846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.
    Hawkins BT; Lundeen TF; Norwood KM; Brooks HL; Egleton RD
    Diabetologia; 2007 Jan; 50(1):202-11. PubMed ID: 17143608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited.
    Simpson IA; Appel NM; Hokari M; Oki J; Holman GD; Maher F; Koehler-Stec EM; Vannucci SJ; Smith QR
    J Neurochem; 1999 Jan; 72(1):238-47. PubMed ID: 9886075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased sensitivity of in vivo platelet aggregation in rabbits after alloxan or streptozotocin.
    Honour AJ; Hockaday TD
    Br J Exp Pathol; 1976 Feb; 57(1):1-10. PubMed ID: 131572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of exposure to 50 Hz magnetic field with or without insulin on blood-brain barrier permeability in streptozotocin-induced diabetic rats.
    Gulturk S; Demirkazik A; Kosar I; Cetin A; Dökmetas HS; Demir T
    Bioelectromagnetics; 2010 May; 31(4):262-9. PubMed ID: 19953571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin.
    Havel PJ; Uriu-Hare JY; Liu T; Stanhope KL; Stern JS; Keen CL; Ahrén B
    Am J Physiol; 1998 May; 274(5):R1482-91. PubMed ID: 9612417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of alloxan- and streptozotocin-induced insulin deficiency on somatostatin and glucagon secretion by the perfused isolated rat pancreatico-duodenal preparation.
    Goto Y; Berelowitz M; Frohman LA
    Diabetologia; 1981; 20(1):66-71. PubMed ID: 6110604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased leptin permeation across the blood-brain barrier after chronic alcohol ingestion.
    Pan W; Barron M; Hsuchou H; Tu H; Kastin AJ
    Neuropsychopharmacology; 2008 Mar; 33(4):859-66. PubMed ID: 17487223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin.
    Mizuno TM; Makimura H; Silverstein J; Roberts JL; Lopingco T; Mobbs CV
    Endocrinology; 1999 Oct; 140(10):4551-7. PubMed ID: 10499510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats.
    Lin CY; Higginbotham DA; Judd RL; White BD
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1084-91. PubMed ID: 11934674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus.
    McCall AL; Millington WR; Wurtman RJ
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5406-10. PubMed ID: 6752947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with glucose increases entry of urocortin into mouse brain.
    Kastin AJ; Akerstrom V
    Peptides; 2001 May; 22(5):829-34. PubMed ID: 11337097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
    Liu Z; Li J; Zeng Z; Liu M; Wang M
    Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin enters the brain by a saturable system independent of insulin.
    Banks WA; Kastin AJ; Huang W; Jaspan JB; Maness LM
    Peptides; 1996; 17(2):305-11. PubMed ID: 8801538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular perfusion and blood-brain glucose transport in acute and chronic hyperglycemia.
    Harik SI; LaManna JC
    J Neurochem; 1988 Dec; 51(6):1924-9. PubMed ID: 3183668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitreous fluorophotometry in the alloxan- and streptozocin-treated rat.
    Jones CW; Cunha-Vaz JG; Rusin MM
    Arch Ophthalmol; 1982 Jul; 100(7):1141-5. PubMed ID: 6212041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier permeability to sodium. Modification by glucose or insulin?
    Knudsen GM; Jakobsen J
    J Neurochem; 1989 Jan; 52(1):174-8. PubMed ID: 2642296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.